BioSpace News Archive

Drug Development

Vetigenics Announces Publication Of Comprehensive Preclinical Data For Anti-Canine CTLA4 Monoclonal Antibody

Vetigenics, an animal health biotechnology company, has announced preclinical data that paves the way for clinical evaluation of the first entirely canine, anti-CTLA4 antibody to promote anti-tumor immunity in dogs with immune-responsive cancers.

January 5, 2022
·
4 min read
BioMidwest

Meridian Bioscience Receives FDA-Clearance for the Curian® Campy Assay

Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the Curian® Campy assay has received U.S. Food and Drug Administration (FDA) clearance.

January 5, 2022
·
3 min read
MingMed to Present at the 40th Annual J.P. Morgan Healthcare Conference

MingMed Biotechnology today announced that Ms. Liza Ko , Chief Financial Officer of the company, has been invited to present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 10, 2022 at 08:00 AM ET.

January 5, 2022
·
1 min read
BioMidwest

Xoran Announces 50th VetCAT Installation at Perkins Road Animal Hospital

Xoran Technologies announces the installation of its 50th VetCAT at Perkins Road Animal Hospital— a major milestone for Xoran and their state-of-the-art, 3D computed tomography imaging solution.

January 5, 2022
·
2 min read
BioMidwest

Stryker to host conference call on January 27, 2022

Stryker announced that it will host a conference call on Thursday, January 27, 2022 at 4:30 p.m., Eastern Time, to discuss the Company’s operating results for the quarter ended December 31, 2021 and provide an operational update.

January 5, 2022
·
1 min read
Business

Invenra, Inc. Appoints Daniel S. Pereira, Ph.D., as Chief Scientific Officer

Invenra, Inc., a biotechnology company focused on the discovery and development of multispecific antibodies for immuno-oncology, today announced the appointment of Daniel S. Pereira, Ph.D., as Chief Scientific Officer.

January 5, 2022
·
3 min read
Policy

Median Technologies Announces Outstanding Lung Nodule Detection (CADe1) Performance for iBiopsy® Lung Cancer Screening

Median Technologies (ALMDT:PA) announces outstanding performance for its iBiopsy® Lung Cancer Screening (LCS) CADe algorithm in detecting potentially cancerous lung nodules.

January 5, 2022
·
5 min read
AM Pharma to Participate in Upcoming Investor Conferences - Jan 05, 2022

AM Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, announced that Erik van den Berg, the Company’s Chief Executive Officer, and Lars Boesgaard, Chief Financial Officer, will participate in the following investor conferences.

January 5, 2022
·
1 min read
Modapills Ltd New Year Plan includes New Payment Gateway System and Offers

Modapills Ltd (the company), an FDA-approved medications company based out of London, United Kingdom has recently announced that the company has adopted a new payment method that includes Credit Cards and Crypto through CoinPayment.

January 5, 2022
·
2 min read
Business

Tevogen Bio Appoints Yale Public Health Dean Dr. Sten H. Vermund, Preeminent Global Expert in COVID-19 and Infectious Disease Epidemiology, to its Innovation and Public Health Advisory Council

Tevogen Bio, a clinical stage biotechnology company, announces the appointment of Sten H. Vermund, M.D., Ph.D., Dean and Anna M.R. Lauder Professor in the Yale School of Public Health and Professor in Pediatrics in the Yale School of Medicine, to its Innovation and Public Health Advisory Council.

January 5, 2022
·
5 min read